References
- Beck A , GoetschL, DumontetC, CorvaiaN. Strategies and challenges for the next generation of antibody–drug conjugates. Nat. Rev. Drug Discov.16(May), 315–337 (2017).
- Dean AQ , LuoS, TwomeyJD, ZhangB. Targeting cancer with antibody-drug conjugates: promises and challenges. MABS13(1), 1–23 (2021).
- Yamazaki CM , YamaguchiA, AnamiYet al. Antibody–drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nat. Commun.12(1), 3528 (2021).
- Nadkarni DV , LeeJ, JiangQet al. Impact of drug conjugation and loading on target antigen binding and cytotoxicity in cysteine antibody–drug conjugates. Mol. Pharmaceutics18, 889–897 (2021).
- Conilh L , SadilkovaL, ViricelW, DumontetC. Payload diversifcation: a key step in the development of antibody–drug conjugates. J. Hematol. Oncol.16, 3 (2023).
- Dere R , YiJ-H, LeiCet al. PK assays for antibody–drug conjugate: case study with ado-trastuzmab emtansine. Bioanalysis5(9), 1025–1040 (2013).
- Cahuzac H , DevelL. Analytical methods for the detection and quantification of ADCs in biological matrices. Pharmaceuticals (Basel)13(12), 462 (2020).
- Chang H-P , ShahDK. Determination of ADC concentration by ligand-binding assays. Methods Mol. Biol.2078, 361–369 (2020).
- US Pharmacopeia. USP <1033>: Validation of biological assays. doi: 10.31003/USPNF_M912_01_01 (2023).
- ICH. Validation of analytical procedures Q2(R2). ICH Harmonised Guideline (2022).
- Bursa F , YellowleesA, BishopAet al. Estimation of ELISA results using a parallel curve analysis. J. Immunol. Meth.486, 112836 (2020).
- Wilson R . Design of experiment in assessing robustness and for qualification of a cell-based potency assay. Bioanalysis10(10), 1083–1097 (2013).
- US Pharmacopeia. USP <1010> Analytical data: interpretation and treatment.
- Pearn WL , ShuMH. Lower confidence bounds with sample size information for Cpm applied to production yield assurance. Int. J. Prod. Res.41(15), 3581–3599 (2003).
- Pearn WL , ShuMH, HsuBM. Testing process capability based on Cpm in the presence of random measurement errors. J. Appl. Stat.32(10), 1003–1024 (2014).
- US Food and Drug Administration. Guidance for industry: bioanalytical method validation. www.fda.gov/media/162903/download
- European Medicines Agency. Guideline on validation of bioanalytical methods. www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf